PROGEN — Prostatype Genomics AB Share News
0.000.00%
Last trade - 00:00- SEK27.88m
- SEK24.11m
- SEK0.59m
Brief: Prostatype Genomics: Final Outcome Of Preferential Share Issue
Brief: Prostatype Genomics Announces Preliminary Outcome Of Share Issue
Brief: Prostatype Genomics Appoints Professor Gerald Andriole As CMO
Brief: Prostatype Genomics To Cooperate With Spanish Eurofins Megalab
Brief: Prostatype Genomics Decides On Rights Issue Of About SEK 34.3 Mln
Brief: Prostatype Q4 EBITDA Loss SEK 7.7 Million
Brief: Prostatype Genomics, Life Genomics Enter Agreement
Brief: Prostatype Genomics Q3 Oper Loss Widens To SEK 7.6 Mln
Brief: Prostatype Genomics AB Says Sales In 2022 Are Estimated To Amount To Sek 700,000
Brief: Prostatype Genomics Q2 Operating Loss Widens To SEK 7.4 Million
Brief: Prostatype Announces Outcome Of Rights Issue Of Units
Brief: Prostatype Genomics Q1 EBITDA Loss At 5.1 Mln
Brief: Prostatype Genomics Starts Cooperation With Capio Solna Urologi
Brief: Prostatype Genomics Delivers First Order To Great Britain
Brief: Prostatype Genomics Establishes Subsidiary In The U.S.
Brief: Prostatype Genomics Q4 EBITDA Loss Widens To SEK 5.7 Mln
Brief: Prostatype Announces Outcome Of Exercise Of Warrants Of Series TO 1
Brief: Prostatype Genomics Q3 EBITDA Stable At SEK 3.6 Mln
Brief: Board Of Directors And Management Of Prostatype Genomics AB Enter Into Agreements Regarding Lock Up